<DOC>
	<DOCNO>NCT01639625</DOCNO>
	<brief_summary>They include patient candidate complete concurrent treatment endocavitary brachytherapy External radiation therapy + QT base weekly cisplatin .</brief_summary>
	<brief_title>Concurrent Treatment Squamous Cell Carcinoma Adenocarcinoma Cervix With CIGB-300 Local Application</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Stages IIA IIB FIGO classification . Age 21 70 year . ECOG performance status 01 . No history another neoplastic disease . Value Hemoglobin ≥ 9 g / l. Total leukocyte count ≥ 3.0 x 109 / L. Absolute neutrophil count ≥ 1.5 x 109 / L. Platelets ≥ 100,000 x mm3 . Total bilirubin ≤ 1.5 time ULN , SGOT SGPT ≤ 2.5 time upper limit normal . Creatinine ≤ 2 mg / dL creatinine clearance calculate ≥ 60 ml / min ( accord CockcroftGault formula ) Patients childbearing age use adequate contraception method treatment prevent pregnancy . Life expectancy ≥ 12 month Measurable disease Informed consent sign patient Pregnancy lactation period . Presence lymph node metastasis hematogenous extrapelvic know . Uncontrolled intercurrent disease , include active infection , symptomatic congestive heart failure , unstable angina cardiac arrhythmia psychiatric illness involve incompetence patient . Other malignancy , exception basal cell carcinoma tumor appropriate treatment receive showing diseasefree period ≥ 5 year . Hepatitis B C active , positive serology HIV . Atopy history severe / severe asthma . A history autoimmune disease . Presence significant abnormality ECG perform within 14 day prior admission . Diseases prevent patient give inform consent ability collaborate trial . Participating another clinical trial ``</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>